ニュージャージーにおけるアルツハイマー病の臨床試験
ニュージャージー内の拠点で、アルツハイマー病に関する25件の研究が参加者を募集しています。
ニュージャージー内の都市
公式研究テキスト（英語）
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/30更新 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Bio Behavioral Health, Toms River
被験者募集中第2相
55歳以上 · 全性別 · 2026/09/29更新 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1664, Princeton
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/28更新 · NCT06937229A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- The Cognitive and Research Center of New Jersey - Springfield- Site Number : 8400005, Springfield
被験者募集中第2相
55歳〜85歳 · 全性別 · 2026/09/22更新 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Memory Research Institute - CenExel - PPDS, Toms River
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/22更新 · NCT06585787Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
被験者募集中
18歳以上 · 全性別 · 2026/09/21更新 · NCT05048966Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Research - Toms River, Toms River
被験者募集中第2相
55歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- The Cognitive and Research Center of New Jersey, Ridgewood
- The Cognitive and Research Center of New Jersey, Springfield
被験者募集中第3相
50歳〜90歳 · 全性別 · 2026/09/21更新 · NCT07177352Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
- Hackensack Medical Center, Hackensack
被験者募集中
50歳〜100歳 · 全性別 · 2026/09/17更新 · NCT05295615A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/09/17更新 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2650, Toms River
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011745A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/16更新 · NCT07821658A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Global Medical Institutes LLC; Princeton Medical Institute, Princeton
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011732Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0059, Livingston
- Local Institution - 0081, Toms River
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/01更新 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- The Cognitive and Research Center of New Jersey - Ridgewood ( Site 1064), Ridgewood
- The Cognitive and Research Center of NJ ( Site 1057), Springfield
- CenExel- AMRI ( Site 1018), Toms River
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/08/26更新 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
被験者募集中第1相
50歳〜85歳 · 全性別 · 2026/08/24更新 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/08/20更新 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Rutgers-Robert Wood Johnson Medical School, New Brunswick
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
被験者募集中第3相
55歳以上 · 全性別 · 2026/07/07更新 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- CenExel-HRI, Marlton
被験者募集中第1相健康なボランティア歓迎
45歳〜85歳 · 全性別 · 2026/06/04更新 · NCT06657768A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
被験者募集中観察研究
19歳以上 · 全性別 · 2026/04/21更新 · NCT06810960Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
被験者募集中第2相健康なボランティア歓迎
18歳〜120歳 · 全性別 · 2026/04/13更新 · NCT07012993Exercise to Improve Brain Health in Older African Americans
- Rutgers, The State University of New Jersey - Newark campus, Newark
被験者募集中第2相健康なボランティア歓迎
60歳以上 · 全性別 · 2026/02/20更新 · NCT05597124ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
- Rutgers - Institute for Health, New Brunswick
被験者募集中第2相健康なボランティア歓迎
60歳以上 · 全性別 · 2026/02/06更新 · NCT07392723Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/02/02更新 · NCT07105709ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。